Acid-triggered release of doxorubicin from a hydrazone-linked Gd3+-texaphyrin conjugate

Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator

(2016) Gregory Thiabaud et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Biotin-guided anticancer drug delivery with acidity-triggered drug release

(2015) Soyeon Park et al.   CHEMICAL COMMUNICATIONS

Mechanisms of Drug Release in Nanotherapeutic Delivery Systems

(2015) Pamela T. Wong et al.   CHEMICAL REVIEWS

Synthesis of an acid-labile polymeric prodrug DOX-acetal-PEG-acetal-DOX with high drug loading content for pH-triggered intracellular drug release

(2015) Hairong Wang et al.   Polymer Chemistry

Cover Picture: Photoinduced Reduction of PtIVwithin an Anti-Proliferative PtIV-Texaphyrin Conjugate (Chem. Eur. J. 29/2014)

(2014) Grégory Thiabaud et al.   CHEMISTRY-A EUROPEAN JOURNAL

A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery

(2013) Changli Du et al.   BIOMATERIALS

Recent Developments in Texaphyrin Chemistry and Drug Discovery

(2013) Christian Preihs et al.   INORGANIC CHEMISTRY

A texaphyrin–oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells

(2012) Jonathan F. Arambula et al.   MedChemComm

Uridine-based paramagnetic supramolecular nanoaggregate with high relaxivity capable of detecting primitive liver tumor lesions

(2011) Sankarprasad Bhuniya et al.   BIOMATERIALS

Cell-Specific, Activatable, and Theranostic Prodrug for Dual-Targeted Cancer Imaging and Therapy

(2011) Santimukul Santra et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Immunotoxins and Anticancer Drug Conjugate Assemblies: The Role of the Linkage between Components

(2011) Franco Dosio et al.   Toxins

Multifunctional Stable and pH-Responsive Polymer Vesicles Formed by Heterofunctional Triblock Copolymer for Targeted Anticancer Drug Delivery and Ultrasensitive MR Imaging

(2010) Xiaoqiang Yang et al.   ACS Nano

Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies

(2009) Anne M. Traynor et al.   INVESTIGATIONAL NEW DRUGS

Motexafin Lutetium-Photodynamic Therapy of Prostate Cancer: Short- and Long-Term Effects on Prostate-Specific Antigen

(2008) H. Patel et al.   CLINICAL CANCER RESEARCH

Motexafin Gadolinium Combined With Prompt Whole Brain Radiotherapy Prolongs Time to Neurologic Progression in Non–Small-Cell Lung Cancer Patients With Brain Metastases: Results of a Phase III Trial

(2008) Minesh P. Mehta et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS